DM² 1ˢᵗ-Gen Demonstrators

The Made Smarter Innovation - Digital Medicines Manufacturing Research Centre (DM²), led by CMAC, is reshaping medicine manufacturing by addressing traditional inefficiencies.

Co-funded by the Made Smarter Innovation Challenge at UK Research and Innovation and industry partners, DM² recognises that data and industrial digital technologies (IDTs) are essential for the development of integrated digital solutions. 

DM² strives to decrease waste, boost efficiency, foster a future-ready workforce, and enhance the responsiveness of the medicines manufacturing industry for faster, sustainable delivery of medicines to patients. Through collaboration with industry and academic partners, DM² co-creates and co-delivers innovations aimed at improving patient outcomes and ensuring the industry's readiness for the future.

The DM² team is working over several integrated delivery Platforms to achieve their goals. To mark the project’s mid-point, the team recently shared their progress at a showcase during CMAC Open Days 2023:

Outline of three interlocking gears in black on a white background.

13 Demonstrators

Across Data, Autonomous Manufacturing, Quality Control Tools, Supply Chain, Engagement and Skills

Icons representing data processing, 3D modeling software, virtual reality headset, and robotic arm.

7 Integrated IDTs

Industrial digital technology developments covering data collation & transformation, machine learning/AI, computer modelling, robotics, digital design and immersive tech

Black icon of a group of people representing teamwork or community.

300* Attendees

Across 3 showcase sessions

* approx. 300 attendees present across 3 days of CMAC Open Days

Platform 1:

The team’s research focuses on data organisation, aiming for data to be Findable, Accessible, Interoperable, and Reusable (FAIR) to enhance its usability in manufacturing. In the first half of the project, the team have developed onotolgy mechanisms to extract biomedical relations from text and Extract, Transform and Load (ETL) tools to simplify data acquisition, databasing and visualisation. Platform 1 has also been involved in the creaion of an automated sessile drop experiment for the real-time testing of tablet disintegration properties. This is an integral part of the testing mechanisms being integrated into the Platform 2 automated micrcoscale tabletting and testing workflow.

A group of diverse people at a conference, engaging with a presentation and discussing research posters, in an indoor conference hall.

People at a conference discussing data visualizations on a large screen, with graphs and charts from University of Strathclyde.

Two women discussing scientific research posters at a conference, with one pointing at a presentation slide on a large monitor displaying charts and graphs.

Watch the video or click on the posters to learn more about Platform 1’s research.

Platform 2:

The team has been working on an autonomous microscale production facility, utilising AI, robotics and computational modelling. The team have created a small-scale manufacturing set-up integrating several technologies and instruments to make and test individual medicine tablets. This has the capacity to run independently on user-defined and/or self-driven experiments. Taking an integrated approach, driven and optimised by computational models and machine learning, helps identify the best formulation and process conditions to maxisimise drug product quality attributes, reduce waste and cut development time.

Two men in business attire discussing scientific research posters at a conference. One man faces away with glasses, the other mans face is visible, and they appear engaged in a discussion. Scientific posters with charts, diagrams, and text are in the background.

Two men sitting at a table with computers and monitor, discussing digital medicine manufacturing at a conference.

Two men are discussing medical formulation process data on digital screens in a conference room, with a large presentation slide on the wall displaying 'Made Smarter', 'Digital Medicines Manufacturing', and logos from UK institutions.

Watch the video or click on the posters to learn more about Platform 2’s research.

Platform 3:

The team’s research is driving digitalisation of quality control processes by developing digital design tools that streamline medicines manufacturing. These are focused on ensuring safe medicine release by creating data-driven, integrated safety and compliance checks in real-time. To achieve this, the team has created a toolbox named ESTAN to get the most out of data and models, increase the reliability of model-based design of experiments and realise cost and time saving benefits. For similar reasons, the team is also running an investigation into quality control mechanisms for a low-dose capsule filling process, using Discrete Element Methods (DEM). Exploring how planning and scheduling of clinical trials can be informed by data generated through this digital quality control research has also been initiated by the team.

A man in a suit presenting a slide about capsule dosage forms at a conference booth, with other attendees in the background.

Three men at a conference looking at a display screen, with conference badges around their necks.

Two men engaged in discussion at a conference with large display screens showing charts and data in the background.

Watch the video or click on the posters to learn more about Platform 3’s research.

Platform 4:

The team is investigating the impact of digital interventions on creating an adaptive supply network that responds to changing materials supply and healthcare provider needs. A number of use cases have been initiated with project partners in the healthcare sector. The first of these cases is centred on digital platform developments, connecting pharmaceutical and medical device manufacturing operations to downstream healthcare product procurement systems to enhance availability. Another case seeks to make clinical trials more resiliant and effective by leveraging extensive analysis of clinical trial supply chain data, and investigating digital interventions to prevent stock-out events. Thirdly, the team is researching production and logistics synchronisation for smart pharmaceutical manufacturing to streamline processes, enhance efficiency, improve stocks and reduce waiting times and operational costs.

Man in a suit and turban explaining a presentation to a group of women at a conference, with a large screen displaying technology and healthcare graphics in the background.

A man explains a presentation on a large screen to two men at a conference or academic event, with multiple posters on the wall behind them.

A man with a beard and turban talking to three other individuals in a conference setting.

Watch the video or click on the posters to learn more about Platform 4’s research.

Platform 5:

The team leads stakeholder engagement and collaboration, and has been running a schedule of activities such as webinars, workshops and conference events to maintain and grow an informed, diverse network of medicines manufatcturing stakeholders. Engagement is critical to building trust in new Industrial Digital Technologies (IDTs) and nurturing an appetite for their implementation and the beneficial changes they will bring. Critical to this is a confident and sufficiently skilled workforce, ready to implement and work alongside new IDTs. To facilitate this, the team has established a SkillsFactory, integrating immersive tech like Augmented Reality, to prepare the workforce for the digital era.